Denne undersøgelses primære virknings- endpoint var at opnå og vedligeholde bekræftede HIV- 1 RNA- koncentrationer < 400 kopier/ ml i 48 uger.
The primary efficacy endpoint for this study was the achievement and maintenance of confirmed HIV-1 RNA concentrations < 400 copies/ ml over 48 weeks.